Host Defense Peptides in the Oral Cavity

Advances in Applied Microbiology

Volumn 63, Issue , 2008, Pages 281-322

  Devine, Deirdre A ^a   Cosseau, Celine ^b  

^a LEEDS DENTAL INSTITUTE   (United Kingdom)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; HISTATIN;

ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; DENTAL CARIES; DRUG MECHANISM; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; INNATE IMMUNITY; MICROORGANISM; MOLECULAR INTERACTION; MOUTH CAVITY; MOUTH DISEASE; MOUTH FLORA; NONHUMAN; REVIEW;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HOST-PATHOGEN INTERACTIONS; HUMANS; MOUTH; MOUTH DISEASES;

EID: 41449087185     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2164(07)00008-1     Document Type: Review

References (191)

1. Aas J.A., Paster B.J., Stokes L.N., Olsen I., and Dewhirst F.E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43 (2005) 5721-5732
2. Altman H., Steinberg D., Porat Y., Mor A., Fridman D., Friedman M., and Bachrach G. In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J. Antimicrob. Chemother. 58 (2006) 198-201
3. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Annals Periodontol. 4 (1999) 1-6
4. Babaahmady K.G., Marsh P.D., Challacombe S.J., and Newman H.N. Variations in the predominant cultivable microflora of dental plaque at defined subsites on approximal tooth surfaces in children. Arch. Oral Biol. 42 (1997) 101-111
5. Baev D., Rivetta A., Vylkova S., Sun J.N.N., Zeng G.F., Slayman C.L., and Edgerton M. The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, Histatin 5. J. Biol. Chem. 279 (2004) 55060-55072
6. Ball S.L., Siou G.P., Wilson J.A., Howard A., Hirst B.H., and Hall J. Expression and immunolocalisation of antimicrobial peptides within palatine tonsils. J. Laryngol. Otol. 26 (2007) 1-6
7. Bals R., and Wilson J.M. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell. Molec. Life Sci. 60 (2003) 711-720
8. Barlow P.G., Li Y.X., Wilkinson T.S., Bowdish D.M.E., Lau Y.E., Cosseau C., Haslett C., Simpson A.J., Hancock R.E.W., and Davidson D.J. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leuk. Biol. 80 (2006) 509-520
9. Beighton D., Rippon H.R., and Thomas H.E.C. The distribution of Streptococcus mutans serotypes and dental caries in a group of 5-year-old to 8-year-old Hampshire schoolchildren. Br. Dent. J. 162 (1987) 103-106
10. Benincasa M., Scocchi M., Pacor S., Tossi A., Nobili D., Basaglia G., Busetti M., and Gennaro R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 58 (2006) 950-959
11. Bercier J.G., Al-Hashimi I., Haghighat N., Rees T.D., and Oppenheim F.G. Salivary histatins in patients with recurrent oral candidiasis. J. Oral Path. Med. 28 (1999) 26-29
12. Bissell J., Joly S., Johnson G.K., Organ C.C., Dawson D., McCray P.B., and Guthmiller J.M. Expression of beta-defensins in gingival health and in periodontal disease. J. Oral Path. Med. 33 (2004) 278-285
13. Boman H.G. Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol. 13 (1995) 61-92
14. Bonass W.A., High A.S., Owen P.J., and Devine D.A. Expression of beta-defensin genes by human salivary glands. Oral Microbiol. Immunol. 14 (1999) 371-374
15. Boniotto M., Hazbon M.H., Jordan W.J., Lennon G.P., Eskdale J., Alland D., and Gallagher G. Novel hairpin-shaped primer assay to study the association of the-44 single-nucleotide polymorphism of the DEFB1 gene with early-onset periodontal disease. Clin. Diag. Lab. Immunol. 11 (2004) 766-769
16. Boyar R.M., and Bowden G.H. The microflora associated with the progression of incipient carious lesions in teeth of children living in a water-fluoridated area. Caries Res. 19 (1985) 298-306
17. Brinig M.M., Lepp P.W., Ouverney C.C., Armitage G.C., and Relman D.A. Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease. Appl. Environ. Microbiol. 69 (2003) 1687-1694
18. Brissette C.A., Simonson L.G., and Lukehart S.A. Resistance to human beta-defensins is common among oral treponemes. Oral Microbiol. Immunol. 19 (2004) 403-407
19. Brissette C.A., and Lukehart S.A. Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola. Infect. Immun. 75 (2007) 2307-2315
20. Brogden K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?. Nature Rev. Microbiol. 3 (2005) 238-250
21. Brogden K.A., Heidari M., Sacco R.E., Palmquist D., Guthmiller J.M., Johnson G.K., Jia H.P., Tack B.F., and McCray P.B. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol. Immunol. 18 (2003) 95-99
22. Buck C.B., Day P.M., Thompson C.D., Lubkowski J., Lu W.Y., Lowy D.R., and Schiller J.T. Human alpha-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. USA. 103 (2006) 1516-1521
23. Cai K.H., and Bennick A. Effect of salivary proteins on the transport of tannin and quercetin across intestinal epithelial cells in culture. Biochem. Pharmacol. 72 (2006) 974-980
24. Castagnola M., Inzitari R., Rossetti D.V., Olmi C., Cabras T., Piras V., Nicolussi P., Sanna M.T., Pellegrini M., Giardina B., and Messana I. A cascade of 24 histatins (histatin 3 fragments) in human saliva-Suggestions for a pre-secretory sequential cleavage pathway. J. Biol. Chem. 279 (2004) 41436-41443
25. Chung W.O., and Dale B.A. Innate immune response of oral and foreskin keratinocytes: Utilization of different signaling pathways by various bacterial species. Infect. Immun. 72 (2004) 352-358
26. Concannon S.P., Crowe T.D., Abercrombie J.J., Molina C.M., Hou P., Sukumaran D.K., Raj P.A., and Leung K.P. Susceptibility of oral bacteria to an antimicrobial decapeptide. J. Med. Microbiol. 52 (2003) 1083-1093
27. Curtis M.A., Aduse-Opoku J., and Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit. Rev. Oral Biol. Med. 12 (2001) 192-216
28. Daher K.A., Selsted M.E., and Lehrer R.I. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60 (1986) 1068-1074
29. Dahlen G., and Leonhardt A. A new checkerboard panel for testing bacterial markers in periodontal disease. Oral Microbiol. Immunol. 21 (2006) 6-11
30. Dale B.A., Kimball J.R., Krisanaprakornkit S., Roberts F., Robinovitch M., O'Neal R., Valore E.V., Ganz T., Anderson G.M., and Weinberg A. Localized antimicrobial peptide expression in human gingiva. J. Periodontol. Res. 36 (2001) 285-294
31. Dale B.A., and Fredericks L.P. Antimicrobial peptides in the oral environment: Expression and function in health and disease. Curr. Iss. Molec. Biol. 7 (2005) 119-133
32. Davidson D.J., Currie A.J., Reid G.S.D., Bowdish D.M.E., MacDonald K.L., Ma R.C., Hancock R.E.W., and Speert D.P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172 (2004) 1146-1156
33. den Hertog A.L., van Marle J., van Veen H.A., van't Hof W., Bolscher J.G.M., Veerman E.C.I., and Amerongen A.V.N. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388 (2005) 689-695
34. Devine D.A. Antimicrobial peptides in defence of the oral and respiratory tracts. Molec. Immunol. 40 (2003) 431-443
35. Devine D.A. Cationic antimicrobial peptides in regulation of commensal and pathogenic microbial populations. In: Devine D.A., and Hancock R.E.W. (Eds). "Mammalian Host Defense Peptides" Vol. 1 (2004), Cambridge University Press, Cambridge 9-37
36. Devine D.A., Marsh P.D., Percival R.S., Rangarajan M., and Curtis M.A. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiol. 145 (1999) 965-971
37. Devine D.A., and Hancock R.E.W. Cationic peptides: Distribution and mechanisms of resistance. Curr. Pharm. Design. 8 (2002) 703-714
38. Dixon D.R., and Darveau R.P. Lipopolysaccharide heterogeneity: Innate host responses to bacterial modification of lipid A structure. J. Dent. Res. 84 (2005) 584-595
39. Dixon D.R., Bainbridge B.W., and Darveau R.P. Modulation of the innate immune response within the periodontium. Periodontol. 2000 35 (2004) 53-74
40. Dixon D.R., Reife R.A., Cebra J.J., and Darveau R.P. Commensal bacteria influence innate status within gingival tissues: A pilot study. J. Periodontol. 75 (2004) 1486-1492
41. Dodds M.W.J., Johnson D.A., and Yeh C.K. Health benefits of saliva: A review. J. Dent. 33 (2005) 223-233
42. Dommisch H., Acil Y., Dunsche A., Winter J., and Jepsen S. Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases. Oral Microbiol. Immunol. 20 (2005) 186-190
43. Dommisch H., Chung W.O., Rohani M.G., Williams D., Rangarajan M., Curtis M., and Dale B.A. Protease-activated receptor-2 mediates hBD-2 and CCL20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect. Immun. 75 (2007) 4326-4333
44. Dommisch H., Winter J., Acil Y., Dunsche A., Tiemann M., and Jepsen S. Human beta-defensin (hBD-1,-2) expression in dental pulp. Oral Microbiol. Immunol. 20 (2005) 163-166
45. Dommisch H., Winter J., Willebrand C., Eberhard J., and Jepsen S. Immune regulatory functions of human beta-defensin-2 in odontoblast-like cells. Int. Endod. J. 40 (2007) 300-307
46. Dorschner R.A., Lopez-Garcia B., Peschel A., Kraus D., Morikawa K., Nizet V., and Gallo R.L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 20 (2006) 35-42
47. Duits L.A., Ravensbergen B., Rademaker M., Hiemstra P.S., and Nibbering P.H. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunol. 106 (2002) 517-525
48. Dunsche A., Acil Y., Dommisch H., Siebert R., Schroder J.M., and Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur. J. Oral Sci. 110 (2002) 121-124
49. Dunsche A., Acil Y., Siebert R., Harder J., Schroder J.M., and Jepsen S. Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral Path. Med. 30 (2001) 154-158
50. Eckert R., He J., Yarbrough D.K., Qi F.X., Anderson M.H., and Shi W.Y. Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob. Agents Chemother. 50 (2006) 3651-3657
51. Edwards A.M., Grossman T.J., and Rudney J.D. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells. Infect. Immun. 74 (2006) 654-662
52. Ellen R.P., and Galimanas V.B. Spirochetes at the forefront of periodontal infections. Periodontol. 2000 38 (2005) 13-32
53. Etienne O., Picart C., Taddei C., Haikel Y., Dimarcq J.L., Schaaf P., Voegel J.C., Ogier J.A., and Egles C. Multilayer polyelectrolyte films functionalized by insertion of defensin: A new approach to protection of implants from bacterial colonization. Antimicrob. Agents Chemother. 48 (2004) 3662-3669
54. Falla T., and Zhang L. Therapeutic potential and applications of innate immunity peptides. In: Devine D., and Hancock R. (Eds). "Mammalian Host Defense Peptides" Vol. 1 (2004), Cambridge University Press, Cambridge 69-110
55. Fang X.M., Shu Q., Chen Q.X., Book M., Sahl H.G., Hoeft A., and Stuber F. Differential expression of alpha- and beta-defensins in human peripheral blood. Eur. J. Clin. Invest. 33 (2003) 82-87
56. Feng Z., Jiang B., Chandra J., Ghannoum M., Nelson S., and Weinberg A. Human beta-defensins: Differential activity against candidal species and regulation by Candida albicans. J. Dent. Res. 84 (2005) 445-450
57. Feucht E.C., DeSanti C.L., and Weinberg A. Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol. Immunol. 18 (2003) 359-363
58. Fine D.H., Kaplan J.B., Kachlany S.C., and Schreiner H.C. How we got attached to Actinobacillus actinomycetemcomitans: A model for infectious diseases. Periodontol. 2000 42 (2006) 114-157
59. Frohm Nilsson M., Sandstedt B., Sorensen O., Weber G., Borregaard N., and Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67 (1999) 2561-2566
60. Fukumoto K., Nagaoka I., Yamataka A., Kobayashi H., Yanai T., Kato Y., and Miyano T. Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatric Surg. Int. 21 (2005) 20-24
61. Genco C.A., Maloy W.L., Kari U.P., and Motley M. Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Int. J. Antimicrob. Agents. 21 (2003) 75-78
62. Giacometti A., Cirioni O., Kamysz W., D'Amato G., Silvestri C., Del Prete M.S., Licci A., Riva A., Lukasiak J., and Scalise G. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob. Agents Chemother. 49 (2005) 1249-1252
63. Gibbons R.J. Bacterial adhesion to oral-tissues-a model for infectious-diseases. J. Dent. Res. 68 (1989) 750-760
64. Groenink J., Ruissen A.L.A., Lowies D., van't Hof W., Veerman E.C.I., and Amerongen A.V.N. Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and Streptococcus mutans. J. Dent. Res. 82 (2003) 753-757
65. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., and Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238 (1996) 325-332
66. Gusman H., Travis J., Helmerhorst E.J., Potempa J., Troxler R.F., and Oppenheim F.G. Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect. Immun. 69 (2001) 1402-1408
67. Guthmiller J.M., Vargas K.G., Srikantha R., Schomberg L.L., Weistroffer P.L., McCray P.B., and Tack B.F. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob. Agents Chemother. 45 (2001) 3216-3219
68. Hancock R.E.W., and Devine D.A. Editorial: "Antimicrobial" or "Host Defence" Peptides. In: Devine D.A., and Hancock R.E.W. (Eds). "Mammalian Host Defence Peptides" (2004), Cambridge University Press, Cambridge 1-4
69. Hancock R.E.W., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotech. 24 (2006) 1551-1557
70. Handelsman J. Metagenomics: Application of genomics to uncultured microorganisms. Microbiol. Molec. Biol. Rev. 68 (2004) 669-685
71. Hao Y., Zhou X., Xiao X., Lu J., Zhang F., Hu T., Wu H., and Chen X. Effects of cecropin-XJ on growth and adherence of oral cariogenic bacteria in vitro. Chinese Med. J. 118 (2005) 155-160
72. Hasegawa Y., Mans J.J., Mao S., Lopez M.C., Baker H.V., Handfield M., and Lamont R.J. Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial species. Infect. Immun. 75 (2007) 2540-2547
73. Hazrati E., Galen B., Lu W.Y., Wang W., Yan O.Y., Keller M.J., Lehrer R.I., and Herold B.C. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J. Immunol. 177 (2006) 8658-8666
74. He J., Eckert R., Pharm T., Simanian M.D., Hu C.H., Yarbrough D.K., Qi F.X., Anderson M.H., and Shi W.Y. Novel synthetic antimicrobial peptides against Streptococcus mutans. Antimicrob. Agents Chemother. 51 (2007) 1351-1358
75. Helmerhorst E.J., Alagl A.S., Siqueira W.L., and Oppenheim F.G. Oral fluid proteolytic effects on histatin 5 structure and function. Arch. Oral Biol. 51 (2006) 1061-1070
76. Helmerhorst E.J., Venuleo C., Sanglard D., and Oppenheim F.G. Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5. Antimicrob. Agents Chemother. 50 (2006) 1100-1103
77. Helmerhorst E.J., and Oppenheim F.G. The antifungal mechanisms of antimicrobial peptides. In: Devine D.A., and Hancock R.E.W. (Eds). "Mammalian Host Defense Peptides" Vol. 1 (2004), Cambridge University Press, Cambridge 245-277
78. Hosokawa I., Hosokawa Y., Komatsuzawa H., Goncalves R.B., Karimbux N., Napimoga M.H., Seki M., Ouhara K., Sugai M., Taubman M.A., and Kawai T. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin. Exp. Immunol. 146 (2006) 218-225
79. Hughes A.L. Evolutionary diversification of the mammalian defensins. Cell. Molec. Life Sci. 56 (1999) 94-103
80. Imatani T., Kato T., Minaguchi K., and Okuda K. Histatin 5 inhibits inflammatory cytokine induction from human gingival fibroblasts by Porphyromonas gingivalis. Oral Microbiol. Immunol. 15 (2000) 378-382
81. Isogai E., Isogai H., Matuo K., Hirose K., Kowashi Y., Okumuara K., and Hirata M. Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol. Immunol. 18 (2003) 329-332
82. Jainkittivong A., Johnson D.A., and Yeh C.K. The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol. Immunol. 13 (1998) 181-187
83. Ji S., Kim Y., Min B.M., Han S.H., and Choi Y. Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria. J. Periodontol. Res. 42 (2007) 503-510
84. Joly S., Maze C., McCray P.B., and Guthmiller J.M. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42 (2004) 1024-1029
85. Joly S., Organ C.C., Johnson G.K., McCray P.B., and Guthmiller J.M. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Molec. Immunol. 42 (2005) 1073-1084
86. Jurevic R.J., Bai M., Chadwick R.B., White T.C., and Dale B.A. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: High-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J. Clin. Microbiol. 41 (2003) 90-96
87. Kadowaki T., Baba A., Abe N., Takii R., Hashimoto M., Tsukuba T., Okazaki S., Suda Y., Asao T., and Yamamoto K. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Molec. Pharmacol. 66 (2004) 1599-1606
88. Kantarci A., Hasturk H., and Dyke T.E. Host-mediated resolution of inflammation in periodontal diseases. Periodontol. 2000 40 (2006) 144-163
89. Kilian M., Frandsen E.V.G., Haubek D., and Poulsen K. The etiology of periodontal disease revisited by population genetic analysis. Periodontol. 2000 42 (2006) 158-179
90. Kirkwood K.L., Cirelli J.A., Rogers J.E., and Giannobile W.V. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol. 2000 43 (2007) 294-315
91. Klotman M.E., and Chang T.L. Defensins in innate antiviral immunity. Nature Rev. Immunol. 6 (2006) 447-456
92. Kolenbrander P.E., Palmer R.J., Rickard A.H., Jakubovics N.S., Chalmers N.I., and Diaz P.I. Bacterial interactions and successions during plaque development. Periodontol. 2000 42 (2006) 47-79
93. Krisanaprakornkit S., Kimball J.R., Weinberg A., Darveau R.P., Bainbridge B.W., and Dale D.A. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68 (2000) 2907-2915
94. Krisanaprakornkit S., Kimball J.R., and Dale B.A. Regulation of human beta-defensin-2 in gingival epithelial cells: The involvement of mitogen-activated protein kinase pathways, but not the NF-kappa B transcription factor family. J. Immunol. 168 (2002) 316-324
95. Krisanaprakornkit S., Jotikasthira D., and Dale B.A. Intracellular calcium in signaling human beta-defensin-2 expression in oral epithelial cells. J. Dent. Res. 82 (2003) 877-882
96. Kumar P.S., Griffen A.L., Barton J.A., Paster B.J., Moeschberger M.L., and Leys E.J. New bacterial species associated with chronic periodontitis. J. Dent. Res. 82 (2003) 338-344
97. Lehrer R.I. Primate defensins. Nature Rev. Microbiol. 2 (2004) 727-738
98. Lehrer R.I., and Ganz T. Cathelicidins: A family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9 (2002) 18-22
99. Lepp P.W., Brinig M.M., Ouverney C.C., Palm K., Armitage G.C., and Relman D.A. Methanogenic Archaea and human periodontal disease. Proc. Natl. Acad. Sci. USA. 101 (2004) 6176-6181
100. Li L., Redding S., and Dongari-Bagtzoglou A. Candida glabrata, an emerging oral opportunistic pathogen. J. Dent. Res. 86 (2007) 204-215
101. Lindh L., Svendsen I.E., Svensson O., Cardenas M., and Arnebrant T. The salivary mucin MUC5B and lactoperoxidase can be used for layer-by-layer film formation. J. Colloid Interface Sci. 310 (2007) 74-82
102. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 16 (1993) 329-334
103. Love R.M., and Jenkinson H.F. Invasion of dentinal tubules by oral bacteria. Crit. Rev. Oral Biol. Med. 13 (2002) 171-183
104. Lu Q., Jin L.J., Darveau R.P., and Samaranayake L.P. Expression of human beta-defensins-1 and -2 peptides in unresolved chronic periodontitis. J. Periodontol. Res. 39 (2004) 221-227
105. Lu Q., Samaranayake L.P., Darveau R.P., and Jin L.J. Expression of human beta-defensin-3 in gingival epithelia. J. Periodontol. Res. 40 (2005) 474-481
106. Lu Q., Jayatilake J., Samaranayake L.P., and Jin L.J. Hyphal invasion of Candida albicans inhibits the expression of human beta-defensins in experimental oral candidiasis. J. Invest. Dermatol. 126 (2006) 2049-2056
107. Lundy F.T., Orr D.F., Shaw C., Lamey P., and Linden G.J. Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingival crevicular fluid-A MALDI-MS approach. Molec. Immunol. 42 (2005) 575-579
108. Mackay B.J., Denepitiya L., Iacono V.J., Krost S.B., and Pollock J.J. Growth-inhibitory and bactericidal effects of human-parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect. Immun. 44 (1984) 695-701
109. Mager D.L., Ximenez-Fyvie L.A., Haffajee A.D., and Socransky S.S. Distribution of selected bacterial species on intraoral surfaces. J. Clin. Periodontol. 30 (2003) 644-654
110. Maisetta G., Batoni G., Esin S., Luperini F., Pardini M., Bottai D., Florio W., Giuca M.R., Gabriele M., and Campa M. Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob. Agents Chemother. 47 (2003) 3349-3351
111. Maisetta G., Batoni G., Esin S., Raco G., Bottai D., Favilli F., Florio W., and Campa M. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids. Antimicrob. Agents Chemother. 49 (2005) 1245-1248
112. Marsh P.D. Are dental diseases examples of ecological catastrophes?. Microbiol. 149 (2003) 279-294
113. Marsh P.D. Dental plaque: Biological significance of a biofilm and community life-style. J. Clin. Periodontol. 32 (2005) 7-15
114. Mathews M., Jia H.P., Guthmiller J.M., Losh G., Graham S., Johnson G.K., Tack B.F., and McCray P.B. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67 (1999) 2740-2745
115. Mickels N., McManus C., Massaro J., Friden P., Braman V., D'Agostino R., Oppenheim F., Warbington M., Dibart S., and Van Dyke T. Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis. J. Clin. Periodontol. 28 (2001) 404-410
116. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., Roche F.M., Mu R., Doho G.H., Pistolic J., Powers J.P., Bryan J., et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176 (2006) 2455-2464
117. Mosca D.A., Hurst M.A., So W., Viajar B.S.C., Fujii C.A., and Falla T.J. IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. 44 (2000) 1803-1808
118. Murakami Y., Nagata H., Amano A., Takagaki M., Shizukuishi S., Tsunemitsu A., and Aimoto S. Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis. Infect. Immun. 59 (1991) 3284-3286
119. Murakami Y., Tamagawa H., Shizukuishi S., Tsunemitsu A., and Aimoto S. Biological role of an arginine residue present in a histidine-rich peptide which inhibits hemagglutination of Porphyromonas gingivalis. FEMS Microbiol. Lett. 98 (1992) 201-204
120. Murakami M., Ohtake T., Dorschner R.A., and Gallo R.L. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 81 (2002) 845-850
121. Murakami Y., Xu T., Helmerhorst E.J., Ori G., Troxler R.F., Lally E.T., and Oppenheim F.G. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 17 (2002) 143-149
122. Muralidharan R., and Bobek L.A. Antifungal activity of human salivary mucin-derived peptide, MUC7 12-mer, in a murine model of oral candidiasis. J. Peptide Res. 66 (2005) 82-89
123. Nieuw Amerongen A.V., and Veerman E.C.I. Saliva-the defender of the oral cavity. Oral Dis. 8 (2002) 12-22
124. Niyonsaba F., Nagaoka I., and Ogawa H. Human defensins and cathelicidins in the skin: Beyond direct antimicrobial properties. Crit. Rev. Immunol. 26 (2006) 545-575
125. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., Nagaoka I., Okumura K., and Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127 (2007) 594-604
126. Noguchi T., Shiba H., Komatsuzawa H., Mizuno N., Uchida Y., Ouhara K., Asakawa R., Kudo S., Kawaguchi H., Sugai M., and Kurihara H. Syntheses of prostaglandin E-2 and E-cadherin and gene expression of beta-defensin-2 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Inflamm. 27 (2003) 341-349
127. Norskov-Lauritsen N., and Kilian M. Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int. J. Syst. Evol. Microbiol. 56 (2006) 2135-2146
128. Okumura K., Itoh A., Isogai E., Hirose K., Hosokawa Y., Abiko Y., Shibata T., Hirata M., and Isogai H. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett. 212 (2004) 185-194
129. Oppenheim F.G., Xu T., McMillian F.M., Levitz S.M., Diamond R.D., Offner G.D., and Troxler R.F. Histatins, a novel family of histidine-rich proteins in human-parotid secretion-Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 263 (1988) 7472-7477
130. Ouhara K., Komatsuzawa H., Yamada S., Shiba H., Fujiwara T., Ohara M., Sayama K., Hashimoto K., Kurihara H., and Sugai M. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. J. Antimicrob. Chemother. 55 (2005) 888-896
131. Ouhara K., Komatsuzawa H., Shiba H., Uchida Y., Kawai T., Sayama K., Hashimoto K., Taubman M.A., Kurihara H., and Sugai M. Actinobacillus actinomycetemcomitans outer membrane protein 100 triggers innate immunity and production of beta-defensin and the 18-kilodalton cationic antimicrobial protein through the fibronectin-integrin pathway in human gingival epithelial cells. Infect. Immun. 74 (2006) 5211-5220
132. Paquette D.W., Simpson D.M., Friden P., Braman V., and Williams R.C. Safety and clinical effects of topical histatin gels in humans with experimental gingivitis. J. Clin. Periodontol. 29 (2002) 1051-1058
133. Paramonov N., Bailey D., Rangarajan M., Hashim A., Kelly G., Curtis M.A., and Hounsell E.F. Structural analysis of the polysaccharide from the lipopolysaccharide of Porphyromonas gingivalis strain W50. Eur. J. Biochem. 268 (2001) 4698-4707
134. Paster B.J., Olsen I., Aas J.A., and Dewhirst F.E. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol. 2000 42 (2006) 80-87
135. Payne J.B., Iacono V.J., Crawford I.T., Lepre B.M., Bernzweig E., and Grossbard B.L. Selective effects of histidine-rich polypeptides on the aggregation and viability of Streptococcus mutans and Streptococcus sanguis. Oral Microbiol. Immunol. 6 (1991) 169-176
136. Perron G.G., Zasloff M., and Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Royal Soc. B-Biol. Sci. 273 (2006) 251-256
137. Peschel A., and Sahl H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nature Rev. Microbiol. 4 (2006) 529-536
138. Petersen P.E., Bougeois D., Ogawa H., Estupinan-Day S., and Nyiaye C. The global burden of oral diseases and risks to oral health. Bull. World Health Organ. 83 (2005) 661-669
139. Piludu M., Lantini M.S., Cossu M., Piras M., Oppenheim F.G., Helmerhorst E.J., Siqueira W., and Hand A.R. Salivary histatins in human deep posterior lingual glands (of von Ebner). Arch. Oral Biol. 51 (2006) 967-973
140. Pisano E., Cabras T., Montaldo C., Piras V., Inzitari R., Olmi C., Castagnola M., and Messana I. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur. J. Oral Sci. 113 (2005) 462-468
141. Pochet S., Tandel S., Querriere S., Tre-Hardy M., Garcia-Marcos M., De Lorenzi M., Vandenbranden M., Marino A., Devleeschouwer M., and Dehaye J.P. Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Molec. Pharmacol. 69 (2006) 2037-2046
142. Porat Y., Marynka K., Tam A., Steinberg D., and Mor A. Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora. Antimicrob. Agents Chemother. 50 (2006) 4153-4160
143. Premratanachai P., Joly S., Johnson G.K., McCray P.B., Jia H.P., and Guthmiller J.M. Expression and regulation of novel human beta-defensins in gingival keratinocytes. Oral Microbiol. Immunol. 19 (2004) 111-117
144. Putsep K., Carlsson G., Boman H.G., and Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360 (2002) 1144-1149
145. Quiñones-Mateu M.E., Lederman M.M., Feng Z., Chakraborty B., Weber J., Rangel H.R., Marotta M.L., Mirza M., Jiang B., Kiser P., Medvik K., Sieg S.F., et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 17 (2003) F39-F48
146. Ramage G., Tomsett K., Wickes B.L., Lopez-Ribot J.L., and Redding S.W. Denture stomatitis: A role for Candida biofilms. Oral Surg. Oral Med. Oral Path. Oral Radiol. Endodont. 98 (2004) 53-59
147. Redding S.W., Dahiya M.C., Kirkpatrick W.R., Coco B.J., Patterson T.F., Fothergill A.W., Rinaldi M.G., and Thomas C.R. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg. Oral Med. Oral Path. Oral Radiol. Endodont. 97 (2004) 47-52
148. Roberts A.P., and Mullany P. Genetic basis of horizontal gene transfer among oral bacteria. Periodontol. 2000 42 (2006) 36-46
149. Robinson P.G. The oral manifestations of HIV infection. Int. J. Std Aids 8 (1997) 668-674
150. Rudney J.D., Chen R., and Sedgewick G.J. Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells. J. Dent. Res. 84 (2005) 59-63
151. Rudney J.D., Chen R., and Zhang G. Streptococci dominate the diverse flora within buccal cells. J. Dent. Res. 84 (2005) 1165-1171
152. Rydengard V., Nordahl E.A., and Schmidtchen A. Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis. FEBS J. 273 (2006) 2399-2406
153. Savage D. Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31 (1977) 107-133
154. Sawaki K., Mizukawa N., Yamaai T., Yoshimoto T., Nakano M., and Sugahara T. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res. 22 (2002) 2103-2107
155. Schenkein H.A. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol. 2000 40 (2006) 77-93
156. Schupbach P., Oppenheim F.G., Lendenmann U., Lamkin M.S., Yao Y., and Guggenheim B. Electron-microscopic demonstration of proline-rich proteins, statherin, and histatins in acquired enamel pellicles in vitro. Eur. J. Oral Sci. 109 (2001) 60-68
157. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., and Hancock R.E.W. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169 (2002) 3883-3891
158. Scott M.G., Dullaghan E., Mookherjee N., Glavas N., Waldbrook M., Thompson A., Wang A., Lee K., Doria S., Hamill P., Yu J.J., Li Y., et al. An anti-infective peptide that selectively modulates the innate immune response. Nature Biotech. 25 (2007) 465-472
159. Shelburne C.E., Coulter W.A., Olguin D., Lantz M.S., and Lopatin D.E. Induction of beta-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob. Agents Chemother. 49 (2005) 183-187
160. Shiba H., Mouri Y., Komatsuzawa H., Ouhara K., Takeda K., Sugai M., Kinane D.F., and Kurihara H. Macrophage inflammatory protein-3 alpha and beta-defensin-2 stimulate dentin sialophosphoprotein gene expression in human pulp cells. Biochem. Biophys. Res. Comm. 306 (2003) 867-871
161. Shimada T. Salivary proteins as a defense against dietary tannins. J. Chem. Ecol. 32 (2006) 1149-1163
162. Shimotoyodome A., Kobayashi H., Tokimitsu I., Matsukubo T., and Takaesu Y. Statherin and histatin 1 reduce parotid saliva-promoted Streptococcus mutans strain MT8148 adhesion to hydroxyapatite surfaces. Caries Res. 40 (2006) 403-411
163. Slots J. Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Curr. Opin. Infect. Dis. 20 (2007) 278-283
164. Socransky S.S., and Haffajee A.D. Periodontal microbial ecology. Periodontol. 2000 38 (2005) 135-187
165. Socransky S.S., Haffajee A.D., Smith C., and Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J. Clin. Periodontol. 18 (1991) 766-775
166. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 97 (2001) 3951-3959
167. Sun L.L., Finnegan C.M., Kish-Catalone T., Blumenthal R., Garzino-Demo P., La Terra Maggiore G.M., Berrone S., Kleinman C., Wu Z., Abdelwahab S., Lu W., and Garzino-Demo A. Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection. J. Virol. 79 (2005) 14318-14329
168. Taguchi Y., and Imai H. Expression of beta-defensin-2 in human gingival epithelial cells in response to challenge with Porphyromonas gingivalis in vitro. J. Periodontol. Res. 41 (2006) 334-339
169. Tanaka D., Miyasaki K.Y., and Lehrer R.I. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: A cathelicidin found in human leukocytes and epithelium. Oral Microbiol. Immunol. 15 (2000) 226-231
170. Tanner A.C.R., Milgrom P.M., Kent R., Mokeem S.A., Page R.C., Riedy C.A., Weinstein P., and Bruss J. The microbiota of young children from tooth and tongue samples. J. Dent. Res. 81 (2002) 53-57
171. Tao R.C., Jurevic R.J., Coulton K.K., Tsutsui M.T., Roberts M.C., Kimball J.R., Wells N., Berndt J., and Dale B.A. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob. Agents Chemother. 49 (2005) 3883-3888
172. Teles R.P., Haffajee A.D., and Socransky S.S. Microbiological goals of periodontal therapy. Periodontol. 2000 42 (2006) 180-218
173. Tomasinsig L., and Zanetti M. The cathelicidins-structure, function and evolution. Curr. Prot. Pept. Sci. 6 (2005) 23-34
174. Van Dyke T.E., and Serhan C.N. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82 (2003) 82-90
175. Vankeerberghen A., Nuytten H., Dierickx K., Quirynen M., Cassiman J.J., and Cuppens H. Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J. Periodontol. 76 (2005) 1293-1303
176. Varoga D., Pufe T., Harder J., Schroder J.M., Mentlein R., Meyer-Hoffert U., Goldring M.B., Tillmann B., Hassenpflug J., and Paulsen F. Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arth. Rheum. 52 (2005) 1736-1745
177. Veerayutthwilai O., Byers M.R., Pham T.T.T., Darveau R.P., and Dale B.A. Differential regulation of immune responses by odontoblasts. Oral Microbiol. Immunol. 22 (2007) 5-13
178. Vitorino R., Lobo M.J.C., Duarte J.R., Ferrer-Correia A.J., Domingues P.M., and Amado F.M.L. The role of salivary peptides in dental caries. Biomed. Chromatog. 19 (2005) 214-222
179. Vylkova S., Li X.S., Berner J.C., and Edgerton M. Distinct antifungal mechanisms: Beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob. Agents Chemother. 50 (2006) 324-331
180. Vylkova S., Nayyar N., Li W.S., and Edgerton M. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 51 (2007) 154-161
181. Wade W. Unculturable bacteria-the uncharacterized organisms that cause oral infections. J. Royal Soc. Med. 95 (2002) 81-83
182. Wehkamp J., Schauber J., and Stange E.F. Defensins and cathelicidins in gastrointestinal infections. Curr. Opin. Gastroenterol. 23 (2007) 32-38
183. Wei G.X., Campagna A.N., and Bobek L.A. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Chemother. 57 (2006) 1100-1109
184. Weinberg A., Krisanaprakornkit S., and Dale B.A. Epithelial antimicrobial peptides: Review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9 (1998) 399-414
185. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 21 (2004) 241-254
186. Woo J.S., Jeong J.Y., Hwang Y.J., Chae S.W., Hwang S.J., and Lee H.M. Expression of cathelicidin in human salivary glands. Arch. Otolaryngol. Head Neck Surg. 129 (2003) 211-214
187. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: More than just microbicidal. Trends Immunol. 23 (2002) 291-296
188. Yang D., and Oppenheim J. Multiple functions of antimicrobial peptides in host immunity. In: Devine D., and Hancock R. (Eds). "Mammalian Host Defense Peptides" Vol. 1 (2004), Cambridge University Press, Cambridge 39-68
189. Yoshinari M., Kato T., Matsuzaka K., Hayakawa T., Inoue T., Oda Y., Okuda K., and Shimono M. Adsorption behavior of antimicrobial peptide histatin 5 on PMMA. J. Biomed. Mat. Res. B. Appl. Biomat. 77B (2006) 47-54
190. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415 (2002) 389-395
191. Zhu J.S., Luther P.W., Leng Q.X., and Mixson A.J. Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: Role of endocytosis and treatment implications. Antimicrob. Agents Chemother. 50 (2006) 2797-2805